Trial
NCT01839552
An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients.
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Louisville
Collaborators
James Graham Brown Cancer Center
Condition
Pain
Intervention
Fentanyl Citrate Nasal Spray (FCNS)
Why stopped
Site chose to close due to lack of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-05